High-dose intravenous immunoglobulin infusion as treatment for diffuse scleroderma [8]

British Journal of Dermatology

Volumn 156, Issue 5, 2007, Pages 1058-1060

  Ihn, H ^a,b   Mimura, Y ^a   Yazawa, N ^a   Jinnin, M ^a   Asano, Y ^a   Yamane, K ^a   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE SCLERODERMA; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; LETTER; NAUSEA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SKIN BIOPSY; SKINFOLD THICKNESS;

ADULT; AGED; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; SCLERODERMA, DIFFUSE; TREATMENT OUTCOME;

EID: 34247335464     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07777.x     Document Type: Letter

References (10)

1. Ihn H. The role of TGF-β signaling in the pathogenesis of fibrosis in scleroderma. Arch Immunol Ther Exp 2002 50:325 31.
2. Clements PJ, Lachenbruch PA, Sterz M et al. Cyclosporine in systemic sclerosis. Results of a forty-eight-week open safety study in ten patients. Arthritis Rheum 1993 36:75 83.
3. Steele RW, Burks AW Jr., Williams LW. Intravenous immunoglobulin: new clinical applications. Ann Allergy 1988 60:89 94.
4. Cherin P, Herson S, Wechsler B et al. Intravenous immunoglobulin for polymyositis and dermatomyositis. Lancet 1990 336:116.
5. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980 23:581 90.
6. Clements P, Lachenbruch P, Siebold J et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995 22:1281 5.
7. Levy Y, Sherer Y, Langevitz P et al. Skin score decrease in systemic sclerosis patients treated with intravenous immunoglobulin - a preliminary report. Clin Rheumatol 2000 19:207 11.
8. Amital H, Rewald E, Levy Y et al. Fibrosis regression induced by intravenous immunoglobulin treatment. Ann Rheum Dis 2003 62:175 7.
9. Levy Y, Amital H, Langevitz P et al. Intravenous immunoglobulin modulates cutaneous involvement and reduces skin fibrosis in systemic sclerosis: an open-label study. Arthritis Rheum 2004 50:1005 7.
10. Blank M, Levy Y, Amital H et al. The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice. Arthritis Rheum 2002 46:1689 90.